Patient experience data: Sanofi researchers call for more consistency from FDA
Researchers at drugmaker Sanofi are calling on the FDA to make its publication of patient experience data (PED) in review documentation more consistent after reviewing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.